N6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5′-N-ethylearboxamido-adenosines:: The first example of adenosine-related structures with potent agonist activity at the human A2B adenosine receptor

被引:66
作者
Baraldi, Pier Giovanni [1 ]
Preti, Delia
Tabrizi, Mojgan Aghazadeh
Fruttarolo, Francesca
Saponaroa, Giulia
Baraldi, Stefania
Romagnoli, Romeo
Moorman, Allan R.
Gessi, Stefania
Varani, Katia
Borea, Pier Andrea
机构
[1] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dipartimento Med Clin & Sperimentale, Sez Farmacol, I-44100 Ferrara, Italy
[3] King Pharmaceut Res & Dev Inc, Cary, NC 27513 USA
关键词
adenosine; A(2B) receptors; agonists; N-6-substituted-NECA;
D O I
10.1016/j.bmc.2007.01.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A new series of N-6-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines (24-43) has been synthesised and tested in binding assays at hA(1), hA(2A) and hA(3) adenosine receptors, and in a functional assay at the hA(2B) subtype. The examined compounds displayed high potency in activating A(2B) receptors with good selectivity versus A(2A) subtypes. The introduction of an unsubstituted 4-[(phenylcarbamoyl)-methoxyl-phenyI chain at the N-6 position of 5'-N-ethylcarboxamido -adenosine led us to the recognition of compound 24 as a full agonist displaying the highest efficacy of the series (EC50 hA(2B) = 7.3 nM). These compounds represent the first report about adenosine-related structures capable of activating hA2B subtype in the low nanomolar range. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2514 / 2527
页数:14
相关论文
共 37 条
[1]   Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists [J].
Baraldi, PG ;
Tabrizi, MA ;
Preti, D ;
Bovero, A ;
Romagnoli, R ;
Fruttarolo, F ;
Zaid, NA ;
Moorman, AR ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) :1434-1447
[2]   Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5′-N-ethyluronamide as A1 and A3 adenosine receptor agonists [J].
Baraldi, PG ;
Cacciari, B ;
de Las Infantas, MJP ;
Romagnoli, R ;
Spalluto, G ;
Volpini, R ;
Costanzi, S ;
Vittori, S ;
Cristalli, G ;
Melman, N ;
Park, KS ;
Ji, XD ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) :3174-3185
[3]  
BARALDI PG, 1981, SYNTHESIS-STUTTGART, P727
[4]   Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]-9H-purin-9-yl]-N-ethyl-β-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists [J].
Baraldi, Pier Giovanni ;
Preti, Delia ;
Tabrizi, Mojgan Aghazadeh ;
Fruttarolo, Francesca ;
Romagnoli, Romeo ;
Carrion, Maria Dora ;
Lopez Cara, Luisa Carlota ;
Moorman, Allan R. ;
Varani, Katia ;
Borea, Pier Andrea .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (02) :374-380
[5]   New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist n-ethylcarboxamidoadenosine [J].
Beukers, MW ;
Chang, LCW ;
Künzel, JKVD ;
Mulder-Krieger, T ;
Spanjersberg, RF ;
Brussee, J ;
Ijzerman, AP .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (15) :3707-3709
[6]   Binding thermodynamics at A(1) and A(2A) adenosine receptors [J].
Borea, PA ;
Dalpiaz, A ;
Varani, K ;
Gessi, S ;
Gilli, G .
LIFE SCIENCES, 1996, 59 (17) :1373-1388
[7]   BINDING THERMODYNAMICS OF ADENOSINE A(2A) RECEPTOR LIGANDS [J].
BOREA, PA ;
DALPIAZ, A ;
VARANI, K ;
GUERRA, L ;
GILLI, G .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (04) :461-469
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[10]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099